Examining the Use of Real-World Evidence in the Regulatory Process.

In rare cases, there may be significant off‐label usage, but the reasoning behind this off‐label usage should be carefully considered in terms of its impacts on patient selection. 71 , 72 Significant differences between the patients receiving the off‐label treatment vs. the existing standard of care could exist, resulting in issues of generalizability.

also in 13,097 other papers